The present invention relates to the medical use of inositol for the treatment of reactive muscle fibrosis, e.g. reactive cardiac fibrosis, in a subject. The present invention further relates to methods of treating reactive muscle fibrosis, e.g. reactive cardiac fibrosis by administering inositol to a subject.